UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
BIOANALYTICAL SYSTEMS, INC.
(Exact Name Of Registrant As Specified In Its Charter)
| Indiana | 35-1345024 | |
| (State or other jurisdiction of incorporation or organization) | (IRS Employer Identification No.) |
2701 Kent Avenue
West Lafayette, Indiana 47906
(Address of Principal Executive Offices)
1997 Bioanalytical Systems, Inc. Outside
Director Stock Option Plan
(full title of the plan)
Douglas P. Wieten
Vice President-Finance, Chief Financial
Officer and Treasurer
Bioanalytical Systems, Inc.
2701 Kent Avenue
West Lafayette, Indiana 47906
(Name and address of agent for service)
(765) 463-4527
(Telephone number, including
area code, of agent for service)
Copies to:
Stephen J. Hackman
Ice Miller
One American Square, Box 82001
Indianapolis, Indiana 46282
CALCULATION OF REGISTRATION FEE
|
Title of Securities to be Registered |
Amount to be Registered1 |
Proposed Maximum Offering Price Per Unit2 |
Proposed Maximum Aggregate Offering Price2 |
Amount of Registration Fee |
| Common Stock | 25,000 shares | $2.99 | $74,750 | $6.05 |
| 1 |
These are additional securities of the same class, to be offered pursuant to the
same employee benefit plan as those registered pursuant to Registration No.
333-56127. Pursuant to General Instruction E of Form S-8, this registration
statement covers only the additional shares being registered. |
| 2 |
The registration fee has been calculated pursuant to Rule 457(c) and (h) based
upon the average of the high and low prices reported for the Common Stock on
March 7, 2003. |
The contents of the registrant’s Registration Statement on Form S-8, File No. 333-56127, heretofore filed with the Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended, are incorporated herein by reference.
Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned thereunto duly authorized, in the City of West Lafayette, State of Indiana, on March 10, 2003.
|
BIOANALYTICAL SYSTEMS, INC. By: /s/ Peter T. Kissinger Peter T. Kissinger, President and Chief Executive Officer |
Know all men by these presents, that each person whose signature appears below constitutes and appoints Peter T. Kissinger, his true and lawful attorney-in-fact and agent with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto this attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that those attorney-in-fact and agent, or his substitute, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated on March 10, 2003.
|
/s/ Peter T. Kissinger Peter T. Kissinger |
Chairman, President, Chief Executive Officer, and Director (Principal Executive Officer) |
|
/s/ Douglas P. Wieten Douglas P. Wieten |
Vice President-Finance, Chief Financial Officer and Treasurer (Principal Financial Officer and Principal Accounting Officer) |
|
/s/ Ronald E. Shoup Ronald E. Shoup |
Director |
|
/s/ Candice B. Kissinger Candice B. Kissinger |
Director |
|
/s/ William E. Baitinger William E. Baitinger |
Director |
|
/s/ John A. Kraeutler John A. Kraeutler |
Director |
|
/s/ W. Leigh Thompson W. Leigh Thompson |
Director |
Exhibit Number Assigned in Regulation S-K Item 601 |
Description of Exhibit
|
(4) |
Not applicable |
(5) |
Not applicable |
(15) |
Not applicable |
(23) |
23.01 |
Consent of Ernst & Young |
(99) |
Not applicable |